PITTSBURGH, Sept. 1 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that the company has been recognized in the "2009 Pittsburgh 100" annual ranking of the fastest-growing, privately-held companies in Western Pennsylvania by the Pittsburgh Business Times.
"We see the Pittsburgh 100 as one of the most important lists we publish," said Alan Robertson, publisher of the Pittsburgh Business Times. "The companies on this list represent many industries and many geographic locations around the region. The Pittsburgh 100 companies also represent all different sizes of companies, from small firms to multi-billion dollar operations. The Pittsburgh 100 is proof that the region remains a vibrant, growth-oriented business environment."
invivodata was named to the annual Pittsburgh 100 based on its revenue growth rate from 2006 through 2008. Honored at an awards program at the Duquesne Club in downtown Pittsburgh on August 27, invivodata was ranked the 16th fastest-growing technology company and #87 overall on the list of 100, based on revenue growth.
"We are a proud member of the Pittsburgh business community and are very pleased to once again be included on this list," said Doug Engfer, invivodata president and CEO. "We believe our steady growth stems from our commitment to delivering value with our practical and reliable solutions and services that help pharmaceutical companies collect better data and run more efficient clinical trials."
In the past year, invivodata has led the industry in developing innovative patient and site based ePRO solutions to meet the evolving needs of global clinical trial sponsors. Strong growth in its scientific and regulatory consulting division, PRO Consulting(TM), coupled with expanded partnerships with Contract Research Organizations and integrations with market-leading eClinical systems has enabled the organization to continue delivering consistent results to new and existing customers.
For additional information on invivodata's solutions and services, visit www.invivodata.com.
About invivodata inc.
invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata's solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.
For more information, contact: invivodata inc. Christine Tobin Corporate Communications Specialist (412) 390-3000, ext. 3502 email@example.com
|SOURCE invivodata inc.|
Copyright©2009 PR Newswire.
All rights reserved